Literature DB >> 29333611

Cognitive dysfunction after generalized tonic-clonic status epilepticus in adults.

K N Power1,2, A Gramstad1,3, N E Gilhus1,2, K O Hufthammer4, B A Engelsen1,2.   

Abstract

OBJECTIVES: Generalized tonic-clonic status epilepticus (GTC-SE) is considered a risk for cognitive impairment. Research with standardized tools is scarce and non-conclusive. We systematically assessed short-term and long-term cognitive function after GTC-SE.
MATERIALS AND METHODS: Thirty-three patients were tested after the clinical post-ictal phase of GTC-SE (timepoint 1) and again after 1 year (timepoint 2). Twenty controls were examined with the same tests. Tests from Cambridge Neuropsychological Test Automated Battery were used. Motor screening test (MOT) assessed motor speed, delayed matching to sample (DMS) and paired associates learning (PAL) assessed memory, and Stockings of Cambridge (SOC) assessed executive function. Estimated premorbid IQ and radiologically visible brain lesions were controlled for in adjusted results. Outcome measures were z-scores, the number of standard deviations a score deviates from the mean of a norm population.
RESULTS: At timepoint 1, unadjusted patient results were significantly below both norm and control group performances on all subtests. Patient mean was 1.9 z-scores below controls (P < .001) on PAL total errors. Results remained significant for PAL and DMS after adjustments. Patient results improved at timepoint 2, but memory tests remained lower than norms and for controls. An executive dysfunction emerged on the most complex SOC stage (z-score difference -0.83; P = .008, adjusted difference -0.94; P = .02).
CONCLUSIONS: Memory and learning impairment in the early phase after SE and late developing executive dysfunction remained significant after adjusting for estimated premorbid IQ and pre-SE brain lesions. Results suggest that GTC-SE poses a risk for cognitive impairment.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  CANTAB; cognition; epilepsy; outcome; status epilepticus

Mesh:

Year:  2018        PMID: 29333611     DOI: 10.1111/ane.12898

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  7 in total

1.  HMGB1 Is a Therapeutic Target and Biomarker in Diazepam-Refractory Status Epilepticus with Wide Time Window.

Authors:  Junli Zhao; Yang Zheng; Keyue Liu; Junzi Chen; Nanxi Lai; Fan Fei; Jiaying Shi; Cenglin Xu; Shuang Wang; Masahiro Nishibori; Yi Wang; Zhong Chen
Journal:  Neurotherapeutics       Date:  2020-04       Impact factor: 7.620

2.  Brivaracetam Modulates Short-Term Synaptic Activity and Low-Frequency Spontaneous Brain Activity by Delaying Synaptic Vesicle Recycling in Two Distinct Rodent Models of Epileptic Seizures.

Authors:  Hang Xing; Xiong Han; Sihan Xu; Zhongyu Sun; Shijun Yang
Journal:  J Mol Neurosci       Date:  2022-03-12       Impact factor: 3.444

3.  Levetiracetam vs. Fosphenytoin for Second-Line Treatment of Status Epilepticus: Propensity Score Matching Analysis Using a Nationwide Inpatient Database.

Authors:  Kensuke Nakamura; Hiroyuki Ohbe; Hiroki Matsui; Yuji Takahashi; Aiki Marushima; Yoshiaki Inoue; Kiyohide Fushimi; Hideo Yasunaga
Journal:  Front Neurol       Date:  2020-07-02       Impact factor: 4.003

4.  Sharp-Wave Ripple Frequency and Interictal Epileptic Discharges Increase in Tandem During Thermal Induction of Seizures in a Mouse Model of Genetic Epilepsy.

Authors:  Christine S Cheah; Megan A Beckman; William A Catterall; John C Oakley
Journal:  Front Cell Neurosci       Date:  2021-10-18       Impact factor: 5.505

5.  Proposal for an updated seizure classification framework in clinical trials.

Authors:  Claude Steriade; Michael R Sperling; Bree DiVentura; Meryl Lozano; Renée A Shellhaas; Sudha Kilaru Kessler; Dennis Dlugos; Jacqueline French
Journal:  Epilepsia       Date:  2022-01-07       Impact factor: 6.740

6.  Long non-coding RNA H19 alleviates hippocampal damage in convulsive status epilepticus rats through the nuclear factor-kappaB signaling pathway.

Authors:  Yangmei Xie; Ming Wang; Xiaolin Deng; Yinghui Chen
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

7.  Time-Dependent Impairment of Fear Conditioning and Associated Brain Regions After Pilocarpine-Induced Status Epilepticus.

Authors:  Xiangmiao Qiu; Masako Kinoshita; Anjiao Peng; Wanling Li; Wanlin Lai; Jing Wang; Lin Zhang; Lei Chen
Journal:  Front Behav Neurosci       Date:  2020-08-27       Impact factor: 3.558

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.